Tuesday, May 29, 2012
Don't let RA limit your routineLearn more now about a treatment that may help

All SharePosts Relating To "denosumab"

PJ Hamel

PJ Hamel, Health Guide

(Profile)
Author, breast cancer survivor

Can’t Take a Bisphosphonate? Prolia May Be Right For You

We’re all familiar with bisphosphonates – “the drugs we love to hate.” Prolia (denosumab), which earned FDA approval in June, 2010, is not a bisphosphonate; it’s a new type of “biologic” drug: a monoclonal antibody. Like bisphosphonates, Prolia focuses on osteoclasts, cells that break down your bones,... Read moreChevron
posted 04/09/2011, comments (0)|
Pam Flores

Pam Flores, Health Guide

(Profile)
Patient Blogger, wife, advocate, and caregiver

FDA Approves Prolia™ for Postmenopausal Women at High-Risk for Fracture

"Today's FDA approval of Prolia is the culmination of a scientific journey that started more than 15 years ago with Amgen's discovery of an essential pathway that regulates bone metabolism," said Kevin Sharer, chairman of the board and chief executive officer of Amgen. "Prolia is the result of this discovery and offers an important new medicine... Read moreChevron
PJ Hamel

PJ Hamel, Health Guide

(Profile)
Writer, author, baker, daughter, mom, wife, friend

Groundbreaking Osteoporosis Drug Derailed – at Least Temporarily

For those of us dealing with bone loss, news of a new treatment sparks a certain degree of personal interest: “Hey, maybe it’ll work better than what I’m taking now – tell me more!”Fact is, there aren’t a whole lot of treatments for osteoporosis out there. There’s drugs… and then, there’s... Read moreChevron
PJ Hamel

PJ Hamel, Health Guide

(Profile)
Writer, author, baker, daughter, mom, wife, friend

Blockbuster Osteoporosis Drug Moves Towards FDA Approval

Denosumab, a ground-breaking osteoporosis drug that’s been moving through clinical trials for several years, is set to take the first step towards FDA approval this week.   An advisory panel will meet Thursday to make recommendations as to whether denosumab, which will be marketed under the brand name Prolia, should be approved for... Read moreChevron
Lila de Tantillo

Lila de Tantillo, Health Guide

(Profile)
Journalist, Caregiver

Denosumab: Future Osteoporosis Medications

For those dissatisfied with current drug options for treating osteoporosis: a new medication being developed by Amgen may be making headway toward the U.S. market. Denosumab, as it is called, would be taken by injection twice a year. The drug inhibits bone remodeling by binding to and thereby blocking the function of a protein known as nuclear... Read moreChevron
posted 01/31/2007, comments (0)|

Ask a Question

Get answers from our experts and community members.

Btn_ask_question_med
View all questions (1303) >